期刊文献+

绵阳地区8家医院冠心病患者医药费用控制研究 被引量:1

Medical Cost Control of Patients with Coronary Heart Disease in Eight Hospitals in Mianyang
下载PDF
导出
摘要 目的了解控制医药费用的必要性和可行性,并探讨医药费控制的措施和方法。方法通过医保信息系统提取绵阳地区8家不同地域不同级别的医院2014年至2016年的冠状动脉粥样硬化性心脏病(简称冠心病)病例,随机抽取1600份病例资料,回顾性分析医疗费用构成。结果平均住院天数为13.24d,人均住院费用为12052.22元,平均药占比为35.19%;冠心病治疗药物金额占总药费的72.37%,中成药总金额占冠心病治疗用药金额的37.75%。结论平均住院日高于文献报道。中成药存在扩大化使用、滥用现象。避免药物的不合理使用和滥用,降低药占比,加强医药费用控制和药品监管,降低住院日和药品价格,落实单病种付费,不断完善医保支付方式,能真正使医药费用回归合理,解决“看病贵”的问题。 Objective To understand the necessity and feasibility of controlling medical cost,and to investigate the measures and methods of controlling medical cost.Methods Through the medical insurance system,the patients with coronary heart disease(CHD)were extracted from eight hospitals of different regions and levels in Mianyang from 2014 to 2016,1 600 cases were randomly sampled and the composition of medical cost was retrospectively analyzed.Results The average hospitalization days were 13.24 d and the average hospitalization cost was 12 052.22 Yuan.The average drug proportion was 35.19%,and the amount of drugs for CHD accounted for 72.37%of the total drug cost.The total amount of Chinese patent medicines accounted for 37.75%of the total cost of medication used in the treatment of CHD.Conclusion The average hospitalization days are longer than those reported in the literature.Chinese patent medicines has been widely used and abused.Avoiding the irrational use and abuse of drugs,reducing the drug proportion,strengthening the control of medical cost and drug administration,reducing the hospitalization days and drug prices,implementing single-disease payment,and constantly improving the payment mode of medical insurance can really make the medical cost return to a reasonable level and solve the problem of″high cost of getting medical services″.
作者 余江平 王安民 鲜于剑波 YU Jiangping;WANG An-min;XIANYU Jianbo(Mianyang Central Hospital,Mianyang,Sichuan,China 621000)
出处 《中国药业》 CAS 2019年第14期75-78,共4页 China Pharmaceuticals
基金 四川省基层卫生事业发展研究中心重点项目[SWFZ16-Z-07]
关键词 冠状动脉粥样硬化性心脏病 医疗费用分析 现状调查 合理控费 药占比 coronary heart disease analysis of medical cost investigation of current situation reasonable control cost drug proportion
  • 相关文献

参考文献9

二级参考文献72

共引文献1262

同被引文献13

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部